Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zachary C Hartman

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 20, 2005
Fully deleted adenovirus persistently expressing GAA accomplishes long-term skeletal muscle glycogen correction in tolerant and nontolerant GSD-II miceAnne Kiang, Zachary C Hartman, Shaoxi Liao, et al.
Immunologic Research|December 8, 2010
Polyclonal immune responses to antigens associated with cancer signaling pathways and new strategies to enhance cancer vaccinesTimothy M Clay, Takuya Osada, Zachary C Hartman, et al.
Journal of Virology|November 24, 2006
Adenovirus infection triggers a rapid, MyD88-regulated transcriptome response critical to acute-phase and adaptive immune responses in vivoZachary C Hartman, Anne Kiang, Ruth S Everett, et al.
Journal of Innate Immunity|April 9, 2010
Novel adenovirus vectors 'capsid-displaying' a human complement inhibitorSergey S Seregin, Zachary C Hartman, Daniel M Appledorn, et al.
Virology|February 19, 2008
Replication-attenuated Human Adenoviral Type 4 vectors elicit capsid dependent enhanced innate immune responses that are partially dependent upon interactions with the complement systemZachary C Hartman, Daniel M Appledorn, Delila Serra, et al.
Cancer Research|September 9, 2010
Ligand-independent toll-like receptor signals generated by ectopic overexpression of MyD88 generate local and systemic antitumor immunityZachary C Hartman, Takuya Osada, Oliver Glass, et al.
Cancer Immunology, Immunotherapy : CII|August 4, 2017
An unbiased in vivo functional genomics screening approach in mice identifies novel tumor cell-based regulators of immune rejectionCasey W Shuptrine, Reham Ajina, Elana J Fertig, et al.
Cancer Gene Therapy|February 10, 2023
Clinical trials of self-replicating RNA-based cancer vaccinesMichael A Morse, Erika J Crosby, Jeremy Force, et al.
Cell|August 10, 2019
T-Scan: A Genome-wide Method for the Systematic Discovery of T Cell EpitopesTomasz Kula, Mohammad H Dezfulian, Charlotte I Wang, et al.
ACS Nano|September 11, 2025
TuNa-AI: A Hybrid Kernel Machine To Design Tunable Nanoparticles for Drug DeliveryZilu Zhang, Yan Xiang, Joe Laforet, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 20, 2005
Fully deleted adenovirus persistently expressing GAA accomplishes long-term skeletal muscle glycogen correction in tolerant and nontolerant GSD-II miceAnne Kiang, Zachary C Hartman, Shaoxi Liao, et al.
Immunologic Research|December 8, 2010
Polyclonal immune responses to antigens associated with cancer signaling pathways and new strategies to enhance cancer vaccinesTimothy M Clay, Takuya Osada, Zachary C Hartman, et al.
Journal of Virology|November 24, 2006
Adenovirus infection triggers a rapid, MyD88-regulated transcriptome response critical to acute-phase and adaptive immune responses in vivoZachary C Hartman, Anne Kiang, Ruth S Everett, et al.
Journal of Innate Immunity|April 9, 2010
Novel adenovirus vectors 'capsid-displaying' a human complement inhibitorSergey S Seregin, Zachary C Hartman, Daniel M Appledorn, et al.
Virology|February 19, 2008
Replication-attenuated Human Adenoviral Type 4 vectors elicit capsid dependent enhanced innate immune responses that are partially dependent upon interactions with the complement systemZachary C Hartman, Daniel M Appledorn, Delila Serra, et al.
Cancer Research|September 9, 2010
Ligand-independent toll-like receptor signals generated by ectopic overexpression of MyD88 generate local and systemic antitumor immunityZachary C Hartman, Takuya Osada, Oliver Glass, et al.
Cancer Immunology, Immunotherapy : CII|August 4, 2017
An unbiased in vivo functional genomics screening approach in mice identifies novel tumor cell-based regulators of immune rejectionCasey W Shuptrine, Reham Ajina, Elana J Fertig, et al.
Cancer Gene Therapy|February 10, 2023
Clinical trials of self-replicating RNA-based cancer vaccinesMichael A Morse, Erika J Crosby, Jeremy Force, et al.
Cell|August 10, 2019
T-Scan: A Genome-wide Method for the Systematic Discovery of T Cell EpitopesTomasz Kula, Mohammad H Dezfulian, Charlotte I Wang, et al.
ACS Nano|September 11, 2025
TuNa-AI: A Hybrid Kernel Machine To Design Tunable Nanoparticles for Drug DeliveryZilu Zhang, Yan Xiang, Joe Laforet, et al.
Pageof 6